+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotherapeutics Cell Line Development - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309862
The global market for Biotherapeutics Cell Line Development is estimated at US$88.9 Million in 2023 and is projected to reach US$135.2 Million by 2030, growing at a CAGR of 6.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Transfection & Selection Process segment, which is expected to reach US$28.9 Million by 2030 with a CAGR of 7.9%. The Single Cell Cloning Process segment is also set to grow at 5.8% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $27.1 Million in 2023, and China, forecasted to grow at an impressive 5.5% CAGR to reach $23 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Biotherapeutics Cell Line Development Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biotherapeutics Cell Line Development Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Biotherapeutics Cell Line Development Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as AGC Biologics, Beckman Coulter, Inc., Becton, Dickinson & Company, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 11 Featured):

  • AGC Biologics
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • EMD Millipore Corporation
  • Lonza Group Ltd.
  • MilliporeSigma
  • ProBioGen AG
  • Selexis SA
  • Sony Biotechnology Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Biotherapeutics Cell Line Development - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Biotherapeutics Cell Line Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Biotherapeutics Cell Line Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Transfection & Selection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Transfection & Selection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Transfection & Selection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Single Cell Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Single Cell Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Single Cell Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Biotherapeutics Cell Line Development Market Analysis of Annual Sales in US$ for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 11: USA Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 12: USA Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 13: USA 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
CANADA
  • Table 14: Canada Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 15: Canada Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 16: Canada 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
JAPAN
  • Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 17: Japan Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 18: Japan Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 19: Japan 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
CHINA
  • Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 20: China Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 21: China Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 22: China 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
EUROPE
  • Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 23: Europe Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 24: Europe Historic Review for Biotherapeutics Cell Line Development by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 25: Europe 16-Year Perspective for Biotherapeutics Cell Line Development by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 26: Europe Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 28: Europe 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
FRANCE
  • Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 29: France Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 30: France Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 31: France 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
GERMANY
  • Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 32: Germany Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 33: Germany Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 34: Germany 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
ITALY
  • Table 35: Italy Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 36: Italy Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 37: Italy 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 38: UK Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 39: UK Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 40: UK 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 41: Rest of Europe Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 42: Rest of Europe Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 43: Rest of Europe 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 44: Asia-Pacific Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 45: Asia-Pacific Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 46: Asia-Pacific 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 47: Rest of World Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 48: Rest of World Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 49: Rest of World 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AGC Biologics
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • EMD Millipore Corporation
  • Lonza Group Ltd.
  • MilliporeSigma
  • ProBioGen AG
  • Selexis SA
  • Sony Biotechnology Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

Table Information